Work

P-851. Evaluation of a multifaceted intervention on the management of uncomplicated gram-negative bacteremia

Year: 2025
Type: article
Abstract: Background Randomized, controlled trials found 7 days of antibiotics to be as effective as 14 days for the treatment of uncomplicated Gram-negative bacteremia. The routine use of repeat blood cultures for these uncomplicated infections is low yield and not recommended. A review of the management of these infections at Denver Health found the median duration of therapy was 10 days and nearly two-thirds of patients had blood cultures repeated. A multifaceted intervention was implemented to reduce duration of therapy and use of repeat blood cultures. The purpose of this study was to evaluate the impact of the intervention. Methods This retrospective cohort study took place from 1/2019 - 12/2019 (pre-intervention) and 10/2022 - 9/2023 (post-intervention). 3 interventions were implemented including a) development and dissemination of a guideline for the management of uncomplicated Gram-negative bacteremia which recommends 7 days of therapy and against repeat blood cultures for most patients b) clinical decision support to discourage repeat blood cultures c) prospective review of positive blood cultures with provider feedback performed by an infectious diseases pharmacist. All patients over 18 years of age with a positive blood culture with a Gram-negative organism were included. The primary outcome was duration of therapy pre-and post-intervention. The secondary outcome was proportion of patients with repeat blood cultures. Results Patient demographics were similar between groups. Urinary tract and E. coli were the most common source and pathogen, respectively. Most patients completed therapy with an oral agent; either a fluoroquinolone or cephalosporin. Cefdinir decreased and cephalexin increased based on institutional guidance. The median duration of therapy decreased from 10 to 7 days (p< .01) and fewer patients had repeat blood cultures (60% vs 31%, p< .01). There were fewer cases of C. difficile in the post-intervention group, otherwise no differences in safety outcomes. Conclusion Implementation of a guideline for the management of uncomplicated Gram-negative bacteremia, clinical decision support, and review of positive blood cultures with provider feedback performed by an infectious diseases pharmacist reduced duration of therapy and the use of repeat blood cultures. Disclosures All Authors: No reported disclosures
Language: English
Open Access status: gold
Estimated APC paid: $4,053
OpenAlex ID: W4406955172
FWCI:
Cites:
Cited by:
Related to: 10